Stelo Glucose Biosensor System is the first over-the-counter continuous glucose monitoring (CGM) system for adults. The system uses a sensor that's attached to your skin to keep track of your glucose levels. The sensor can be scanned and read using an app on a smart device, such as a smartphone. You can use Stelo whether or not you have Type 2 diabetes. But this CGM isn't meant for people with problematic hypoglycemia nor for those who use insulin because it can't alert you if you have dangerously low glucose levels. Some side effects of this CGM include skin irritation or pain at or near the sensor site. __Stelo is expected to be available summer of 2024.
Monitor glucose levels
The Dexcom Stelo Glucose Biosensor System is made up of two parts that work together to measure and record your glucose levels throughout the day:
Sensor: The sensor is attached to your skin to measure your glucose levels from just underneath the skin.
Stelo app: The app on your smart device displays and stores the readings.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Choudhary, P., et al. (2015). Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care.
DexCom, Inc. (n.d.). Phones that work with Dexcom apps.
DexCom, Inc. (n.d.). Stelo by Dexcom.
DexCom, Inc. (2024). Stelo by Dexcom first glucose biosensor cleared by FDA as over-the-counter. Business Wire.
U.S. Food and Drug Administration. (2024). FDA clears first over-the-counter continuous glucose monitor.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.